Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.

doi:10.1016/j.jaad.2009.09.018

Paper

Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.

Published Aug 1, 2010 · H. Eun, O. S. Kwon, J. Yeon

Journal of the American Academy of Dermatology

Q1 SJR score

116

Citations

4

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Highly Cited

Study Snapshot

Dutasteride 0.5 mg once daily significantly improved hair growth and was relatively well tolerated for treating male pattern hair loss in a 6-month study.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.

References

Citations